OMER Q4 2018 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$22M+60.0% YoY

Gross Profit

$22M99.3% margin

Operating Income

-$18M-83.9% margin

Net Income

-$24M-106.9% margin

EPS (Diluted)

$-0.48

QoQ Revenue Growth

+377.8%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$96M

Total Liabilities

-$4M

Stockholders' Equity

$650M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$14M	+60.0%
Gross Profit	$22M	$13M	+64.4%
Operating Income	-$18M	-$14M	-30.8%
Net Income	-$24M	-$17M	-42.2%